Simpson Healthcare Wins Major Awards at the ACQ5 Global Awards 2017


Old Lyme, CT: Today, Simpson Healthcare Executives announced that their scientific agency has recently won two major international awards at the ACQ5 Global Awards 2017, including International—Niche Communications Agency of the Year (Healthcare/Pharma) and International—Gamechanger of the Year for Kelly Simpson-Angelini, CEO+CSO of Simpson Healthcare.

The ACQ5 Global Awards 2017 highlight prominent businesses around the globe that have had a great level of impact on their industry and demonstrate leadership in innovation. The awards celebrate the services, industries and organizations that serve the global market landscape.

Simpson Healthcare Executives is honored to have won these two major awards in this year’s ACQ5 Global Awards program. These awards are a testament to the atmosphere of disruptive innovation that lives within Simpson Healthcare, led by our founder, Kelly Simpson-Angelini, CEO+CSO, who has become a leading game-changer in the healthcare industry. She has worked to better shape the ways that the story of science is communicated and why therapeutic brands matter for patients. Her transformative leadership and the impact of the work of her agency has greatly transformed the healthcare experience in a positive way that educates and empowers both physicians and patient stakeholders.

Simpson Healthcare strives to create a better healthcare for the future, and helps our biopharmaceutical clients to deliver precise and personalized medicine to patients who can benefit most from their therapies.

 About the ACQ5 Global Awards 2017:

The ACQ5 Global Awards 2017 Program has been celebrating achievement, brilliance, and innovation in their annual awards program with a rigorous evaluation process based on the ACQ Annual Award Framework (AAA Framework). For more information, please visit

About Simpson Healthcare Executives, LLC:

Simpson Healthcare challenges key healthcare stakeholders to think disruptively about the future of healthcare beyond next year and into the next decade. We support our clients to share the scientific story of the disease they touch and therapies they discover for all in need. For more information, please visit